Yan Wang
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biological Psychiatry top 0.5%
Papers in
-
- Epigenetics and DNA Methylation 99
- RNA modifications and cancer 89
- Cancer-related gene regulation 74
- Ubiquitin and proteasome pathways 41
- Gut microbiota and health 40
- Histone Deacetylase Inhibitors Research 30
- Oncology 148
- Cancer-related Molecular Pathways 36
- Co-authors
- Yongfeng Shang (19 shared papers)Jing Liang (11 shared papers)Luyang Sun (10 shared papers)Yupeng Chen (6 shared papers)Ruifang Li (6 shared papers)Xiaohan Yang (6 shared papers)Lei Shi (10 shared papers)Wei Huang (19 shared papers)
- Journals
- BMC Cancer (10 papers)PLoS ONE (10 papers)Oncology Reports (10 papers)Cell Death and Disease (10 papers)Frontiers in Oncology (9 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yan Wang
709 papers receiving 17.5k citations
Yan Wang's Hit Papers
Peers
Comparison fields: 5 of 185
- Cancer Research 3.0k
- Biological Psychiatry 460
- Molecular Biology 10.6k
- Oncology 2.9k
- Immunology 1.8k
Countries citing papers authored by Yan Wang
This map shows the geographic impact of Yan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Wang more than expected).
Fields of papers citing papers by Yan Wang
This network shows the impact of papers produced by Yan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Wang. The network helps show where Yan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 756 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer Hit paper breakdown → | 2009 | 552 |
| 2 | 2008 | 313 | |
| 3 | 2007 | 275 | |
| 4 | Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism Hit paper breakdown → | 2022 | 258 |
| 5 | 2019 | 249 | |
| 6 | 2020 | 211 | |
| 7 | 2020 | 155 | |
| 8 | 2019 | 132 | |
| 9 | 2012 | 129 | |
| 10 | 2015 | 128 | |
| 11 | 2011 | 128 | |
| 12 | 2008 | 120 | |
| 13 | Long noncoding RNA GAS5-AS1 suppresses growth and metastasis of cervical cancer by increasing GAS5 stability. | 2019 | 118 |
| 14 | 2014 | 116 | |
| 15 | 2013 | 116 | |
| 16 | 2021 | 114 | |
| 17 | 2019 | 113 | |
| 18 | 2010 | 109 | |
| 19 | 2012 | 107 | |
| 20 | 2018 | 104 |
About Yan Wang
Yan Wang is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 756 papers that have together received 17.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (99 papers), RNA modifications and cancer (89 papers), Cancer-related gene regulation (74 papers), Cancer-related molecular mechanisms research (45 papers), Ubiquitin and proteasome pathways (41 papers), Gut microbiota and health (40 papers), Cancer-related Molecular Pathways (36 papers) and Histone Deacetylase Inhibitors Research (30 papers). The work is most often cited by research in Cancer Research (3.0k citations), Biological Psychiatry (460 citations), Molecular Biology (10.6k citations), Oncology (2.9k citations) and Immunology (1.8k citations). Yan Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yongfeng Shang, Jing Liang, Luyang Sun, Yupeng Chen, Ruifang Li, Xiaohan Yang, Lei Shi, Wei Huang, Lin Tian and Yunkai Yang. Their work appears in journals such as BMC Cancer, PLoS ONE, Oncology Reports, Cell Death and Disease and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.